Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 1 | BMC Immunology

Fig. 1

From: Soluble cytotoxic T-lymphocyte–associated antigen 4 (sCTLA-4) as a potential biomarker for diagnosis and evaluation of the prognosis in Glioma

Fig. 1

Magnetic resonance imaging (MRI) of a case of glioblastoma and histopathology of different grade gliomas. a Preoperative T2-weighted axial image showed left occipitotemporal tumor with solid. b Immediate post-operative (at 24 h) T2-weighted axial image. c-f Histopathology of different grade gliomas (WHO I-IV) (Hematoxylin and eosin staining, × 200)

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us